SMT201600261B - Composti oligopeptidici e loro usi - Google Patents

Composti oligopeptidici e loro usi

Info

Publication number
SMT201600261B
SMT201600261B SM201600261T SM201600261T SMT201600261B SM T201600261 B SMT201600261 B SM T201600261B SM 201600261 T SM201600261 T SM 201600261T SM 201600261 T SM201600261 T SM 201600261T SM T201600261 B SMT201600261 B SM T201600261B
Authority
SM
San Marino
Prior art keywords
oligopeptidic compounds
oligopeptidic
compounds
Prior art date
Application number
SM201600261T
Other languages
English (en)
Inventor
Lars Prestegarden
Original Assignee
Cytovation As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytovation As filed Critical Cytovation As
Publication of SMT201600261B publication Critical patent/SMT201600261B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16HIV-1 ; HIV-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SM201600261T 2010-02-01 2016-08-03 Composti oligopeptidici e loro usi SMT201600261B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1001602.0A GB201001602D0 (en) 2010-02-01 2010-02-01 Oligopeptidic compounds and uses therof
PCT/EP2011/051422 WO2011092347A1 (en) 2010-02-01 2011-02-01 Oligopeptidic compounds and uses thereof

Publications (1)

Publication Number Publication Date
SMT201600261B true SMT201600261B (it) 2016-11-10

Family

ID=42084276

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600261T SMT201600261B (it) 2010-02-01 2016-08-03 Composti oligopeptidici e loro usi

Country Status (19)

Country Link
US (2) US8754042B2 (it)
EP (1) EP2531518B1 (it)
JP (1) JP5934654B2 (it)
KR (1) KR101848518B1 (it)
CN (1) CN102781953B (it)
CA (1) CA2788726C (it)
CY (1) CY1117872T1 (it)
DK (1) DK2531518T3 (it)
ES (1) ES2585595T3 (it)
GB (1) GB201001602D0 (it)
HR (1) HRP20160922T1 (it)
HU (1) HUE028094T2 (it)
LT (1) LT2531518T (it)
PL (1) PL2531518T3 (it)
PT (1) PT2531518T (it)
RS (1) RS54992B1 (it)
SI (1) SI2531518T1 (it)
SM (1) SMT201600261B (it)
WO (1) WO2011092347A1 (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201001602D0 (en) 2010-02-01 2010-03-17 Cytovation As Oligopeptidic compounds and uses therof
CN103012562B (zh) * 2011-09-24 2015-01-28 复旦大学 一种双重靶向的d构型多肽及其递药系统
US10039777B2 (en) 2012-03-20 2018-08-07 Neuro-Lm Sas Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
CN103720655B (zh) * 2012-10-11 2016-05-25 上海纳米技术及应用国家工程研究中心有限公司 一种d型多肽介导的靶向脂质体及其制备方法和应用
KR101782634B1 (ko) * 2015-06-29 2017-10-25 주식회사 큐라클 Amigo2와 3-포스포이노시티드-의존 키나아제 1의 결합 억제용 데코이 펩타이드
MA52150A (fr) * 2017-03-16 2020-01-22 Microsintesis Inc Compositions et procédés faisant intervenir des molécules probiotiques
CN108314741B (zh) * 2018-03-22 2021-08-03 中国人民解放军第四军医大学 一种肿瘤血管靶向抗癌肽nkl-dota及其制备方法
GB201810058D0 (en) * 2018-06-19 2018-08-08 Cytovation As Combination therapy using a peptide
KR102073144B1 (ko) * 2018-12-13 2020-02-04 주식회사 엘베이스 올리고펩티드를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물
US20220204560A1 (en) * 2019-05-02 2022-06-30 L-Base Co., Ltd. Novel oligopeptide, and pharmaceutical composition for preventing or treating cancer, comprising the same as an active ingredient
CN110408699A (zh) * 2019-07-11 2019-11-05 福建卫生职业技术学院 肠癌肠道菌群标志物及其应用
GB202000167D0 (en) 2020-01-07 2020-02-19 Cytovation As Composition for treatment of neoplastic lesions
CN115044520B (zh) * 2022-08-12 2022-11-15 北京百奥茵诺生物科技有限公司 一株交替单胞菌及使用其生产单葡萄糖醛酸甘草次酸的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3925542A1 (de) 1989-08-02 1990-02-15 Kallos Verlag Und Versand Gmbh Glueckwunschkarte
US5534110A (en) 1993-07-30 1996-07-09 Lam Research Corporation Shadow clamp
US5595756A (en) 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
FR2739621B1 (fr) 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
DE19840875A1 (de) * 1997-09-02 1999-05-12 Max Delbrueck Centrum Mittel zur Diagnose und zur Therapie von Tumorerkrankungen
JP2002505077A (ja) 1997-12-10 2002-02-19 ワシントン大学 抗病原体システムおよびその使用方法
GB9814527D0 (en) 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
ATE419273T1 (de) 1998-11-13 2009-01-15 Cyclacel Ltd Translokationsvektoren abgeleitet von der antennapedia homeodomain helix 3
FR2849603B1 (fr) 2003-01-07 2006-09-08 Centre Nat Rech Scient Composition pour le transport intracellulaire de macromolecules ou particules biologiques
US7442681B2 (en) * 2004-02-10 2008-10-28 University Of Virginia Patent Foundation Method of inhibiting vascular permeability
US8680041B2 (en) * 2006-10-26 2014-03-25 Genentech, Inc. Genetic variations associated with tumors
KR20080038047A (ko) * 2006-10-27 2008-05-02 김정문 세포핵에서 세포질로의 gsk3 이동을 억제하는 방법 및물질
GB0803352D0 (en) * 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
GB201001602D0 (en) 2010-02-01 2010-03-17 Cytovation As Oligopeptidic compounds and uses therof

Also Published As

Publication number Publication date
KR101848518B1 (ko) 2018-04-12
SI2531518T1 (sl) 2016-09-30
US20130023461A1 (en) 2013-01-24
HRP20160922T1 (hr) 2016-10-07
PT2531518T (pt) 2016-08-12
JP5934654B2 (ja) 2016-06-15
CN102781953A (zh) 2012-11-14
CA2788726A1 (en) 2011-08-04
EP2531518B1 (en) 2016-05-04
CY1117872T1 (el) 2017-05-17
KR20120128135A (ko) 2012-11-26
US20150038407A1 (en) 2015-02-05
PL2531518T3 (pl) 2017-01-31
LT2531518T (lt) 2016-09-26
US9353156B2 (en) 2016-05-31
GB201001602D0 (en) 2010-03-17
HUE028094T2 (en) 2016-11-28
CN102781953B (zh) 2015-02-04
JP2013517787A (ja) 2013-05-20
RS54992B1 (sr) 2016-11-30
ES2585595T3 (es) 2016-10-06
WO2011092347A1 (en) 2011-08-04
DK2531518T3 (en) 2016-08-15
EP2531518A1 (en) 2012-12-12
US8754042B2 (en) 2014-06-17
CA2788726C (en) 2019-04-02

Similar Documents

Publication Publication Date Title
SMT201600261B (it) Composti oligopeptidici e loro usi
BR112012028556A2 (pt) Indóis
DE102011100241A8 (de) Nitridhalbleiterbauteil
DK3225404T3 (da) Fluidpatron
CR20130111A (es) Triazina-oxidiazoles
DE10170954T8 (de) Mikrowellendruckgarer
DE112011104226A5 (de) Käfigmutter
DE102011117046A8 (de) Doppelkupplungswindungsgetriebe
DE112011101226A5 (de) Linearwegmesssystem
DE112011102080A5 (de) Kupplungszentralausrücker
SMT201600211B (it) Composti eterociclici e loro usi
DK2442899T3 (da) Rotorskive
DK2539163T3 (da) Dækventil
DE102011002623A8 (de) Ventilsteuerzeitversteller
DE112011102711A5 (de) Hydrostataktor
DK2448659T3 (da) Rotorskive
DK2447426T3 (da) Vaske-WC
DE102010019119B8 (de) Cuttermesser
DE112010005518A5 (de) Dichtungsmanchette
DE102010038420A8 (de) Reinigungungsvorrichtung
BR112012021749A2 (pt) processos e compostos
DK2596072T3 (da) Bor-forbindelses-suspension
DK2521486T3 (da) Palpometer
CO6801789A2 (es) N-hetarilmetil pirazolilcarboxamidas
DE112011101796A5 (de) Redoxakkumulatoranlage